We use cookies to improve your experience. By continuing to browse this site, you accept our cookie policy.×
Skip main navigation
Aging Health
Bioelectronics in Medicine
Biomarkers in Medicine
Breast Cancer Management
CNS Oncology
Colorectal Cancer
Concussion
Epigenomics
Future Cardiology
Future Medicine AI
Future Microbiology
Future Neurology
Future Oncology
Future Rare Diseases
Future Virology
Hepatic Oncology
HIV Therapy
Immunotherapy
International Journal of Endocrine Oncology
International Journal of Hematologic Oncology
Journal of 3D Printing in Medicine
Lung Cancer Management
Melanoma Management
Nanomedicine
Neurodegenerative Disease Management
Pain Management
Pediatric Health
Personalized Medicine
Pharmacogenomics
Regenerative Medicine

Chronic headache in the elderly

    Karen E Kirkham

    Department of Internal Medicine, Wright State University Boonshoft School of Medicine, 128 E Apple Street, Weber CHE Bldg, 2nd Fl., Dayton, Ohio 45409-2902, OH, USA.

    &
    Glen D Solomon

    † Author for correspondence

    Department of Internal Medicine, Wright State University Boonshoft School of Medicine, 128 E Apple Street, Weber CHE Bldg, 2nd Fl., Dayton, Ohio 45409-2902, OH, USA.

    Published Online:https://doi.org/10.2217/1745509X.5.1.103

    This article covers some of the major headache types found in the geriatric population. Misperceptions regarding headache in the elderly will be addressed and updated with current perspectives from the literature. Both diagnostic and treatment updates are covered, with special emphasis on headaches unique to those over the age of 60 years: giant cell arteritis, hypnic headache, trigeminal neuralgia, paroxysmal hemicrania, cervicogenic headache, short-lasting unilateral neuralgiform headache attacks with conjunctival injection and tearing, and short-lasting unilateral neuralgiform headache attacks with cranial autonomic features. We will focus on both common and unique causes of headache in the elderly. While the medical literature on headache in older patients is rich with case reports, small case series and uncontrolled trials, we will emphasize the last 5 years of medical literature and systematic reviews where they exist.

    Papers of special note have been highlighted as: • of interest •• of considerable interest

    Bibliography

    • Schwaiger J, Kiechl S, Seppi K et al.: Prevalence of primary headaches and cranial neuralgias in men and women aged 55–94 years (Bruneck study). Cephalalgia27(10),1182–1196 (2007).
    • Detsky ME, McDonald DR, Baerlocher MO et al.: Does this patient with headache have a migraine or need neuroimaging? JAMA296(10),1274–1283(2006).
    • Walker RA, Wadman MC: Headache in the elderly. Clin. Geriatr. Med.23(2),291–305, v–vi (2007).
    • Headache Classification Subcommittee of the International Headache Society. The international classification of headache disorders: 2nd edition. Cephalalgia24(Suppl. 1),9–160 (2004).• Latest updated classification for headache disorders.
    • Loder E, Rizzoli P: Tension-type headache. BMJ336(7635),88–92 (2008).
    • Moja PL, Cusi C, Sterzi RR et al.: Selective serotonin re-uptake inhibitors (SSRIs) for preventing migraine and tension-type headaches. Cochrane Database Syst. Rev. (3),CD002919 (2008).
    • Yurekli VA, Akhan G, Kutluhan S et al.: The effect of sodium valproate on chronic daily headache and its subgroups. J. Headache Pain9(1),37–41 (2008).
    • Padberg M, de Bruijn SF, de Haan RJ et al.: Treatment of chronic tension-type headache with botulinum toxin: a double-blind, placebo-controlled clinical trial. Cephalalgia24(8),675–680 (2004).
    • Silberstein SD, Gobel H, Jensen R et al.: Botulinum toxin type A in the prophylactic treatment of chronic tension-type headache: A multicentre, double-blind, randomized, placebo-controlled, parallel-group study. Cephalalgia26(7),790–800 (2006).
    • 10  Melchart D, Streng A, Hoppe A et al.: Acupuncture in patients with tension-type headache: randomised controlled trial. BMJ331(7513),376–382 (2005).
    • 11  Soderberg E, Carlsson J, Stener-Victorin E: Chronic tension-type headache treated with acupuncture, physical training and relaxation training. between-group differences. Cephalalgia26(11),1320–1329 (2006).
    • 12  Diamond S, Bigal ME, Silberstein S et al.: Patterns of diagnosis and acute and preventive treatment for migraine in the united states: Results from the american migraine prevalence and prevention study. Headache47(3),355–363 (2007).
    • 13  Haan J, Hollander J, Ferrari MD: Migraine in the elderly: a review. Cephalalgia27(2),97–106 (2007).• Excellent review of migraine and its unique presentation and management as it relates to the elderly.
    • 14  Lipton RB, Stewart WF, Diamond S et al.: Prevalence and burden of migraine in the united states: data from the American migraine study II. Headache41(7),646–657 (2001).
    • 15  Bigal ME, Liberman JN, Lipton RB: Age-dependent prevalence and clinical features of migraine. Neurology67(2),246–251 (2006).
    • 16  Wijman CA, Wolf PA, Kase CS et al.: Migrainous visual accompaniments are not rare in late life: the Framingham study. Stroke29(8),1539–1543 (1998).
    • 17  Evans RW, Bruining K: New onset migraine in the elderly. Headache42(9),946–947 (2002).
    • 18  Schwaiger J, Kiechl S, Stockner H et al.: Burden of atherosclerosis and risk of venous thromboembolism in patients with migraine. Neurology71(12),937–943 (2008).
    • 19  Detsky ME, McDonald DR, Baerlocher MO et al.: Does this patient with headache have a migraine or need neuroimaging? JAMA296(10),1274–1283 (2006).•• Good systematic review of history and physical findings that should lead to imaging in headache.
    • 20  Eross E, Dodick D, Eross M: The sinus, allergy and migraine study (SAMS). Headache47(2),213–224 (2007).
    • 21  Cady RK, Dodick DW, Levine HL et al.: Sinus headache: a neurology, otolaryngology, allergy, and primary care consensus on diagnosis and treatment. Mayo Clin. Proc.80(7),908–916 (2005).
    • 22  McCrory DC, Gray RN: Oral sumatriptan for acute migraine. Cochrane Database Syst. Rev. (3),CD002915 (2003).
    • 23  Pascual J, Mateos V, Roig C et al.: Marketed oral triptans in the acute treatment of migraine: a systematic review on efficacy and tolerability. Headache47(8),1152–1168 (2007).
    • 24  Hall GC, Brown MM, Mo J, MacRae KD: Triptans in migraine: the risks of stroke, cardiovascular disease, and death in practice. Neurology62(4),563–568 (2004).
    • 25  Colman I, Brown MD, Innes GD et al.: Parenteral metoclopramide for acute migraine: meta-analysis of randomised controlled trials. BMJ329(7479),1369–1373 (2004).
    • 26  Colman I, Friedman BW, Brown MD et al.: Parenteral dexamethasone for acute severe migraine headache: meta-analysis of randomised controlled trials for preventing recurrence. BMJ336(7657),1359–1361 (2008).
    • 27  Bennett MH, French C, Schnabel A et al.: Normobaric and hyperbaric oxygen therapy for migraine and cluster headache. Cochrane Database Syst. Rev. (3),CD005219 (2008).
    • 28  Schroeder BM: AAFP, ACP-ASIM. AAFP/ACP-ASIM release guidelines on the management and prevention of migraines. Am. Fam. Physician67(6), 1392, 1395–1397 (2003).
    • 29  Linde K, Rossnagel K: Propranolol for migraine prophylaxis. Cochrane Database Syst. Rev. (2),CD003225 (2004).
    • 30  Mulleners WM, Chronicle EP: Anticonvulsants in migraine prophylaxis: a cochrane review. Cephalalgia (6),585–597 (2008).
    • 31  Adelman J, Freitag FG, Lainez M et al.: Analysis of safety and tolerability data obtained from over 1,500 patients receiving topiramate for migraine prevention in controlled trials. Pain Med.9(2),175–185 (2008).
    • 32  Pittler MH, Ernst E: Feverfew for preventing migraine. Cochrane Database Syst. Rev. (1),CD002286 (2004).
    • 33  Busch V, Gaul C: Exercise in migraine therapy – is there any evidence for efficacy? A critical review. Headache48(6),890–899 (2008).
    • 34  Robertson BA, Morris ME: The role of cervical dysfunction in migraine: a systematic review. Cephalalgia28(5),474–483 (2008).
    • 35  Naumann M, So Y, Argoff CE et al.: Assessment: botulinum neurotoxin in the treatment of autonomic disorders and pain (an evidence-based review): report of the therapeutics and technology assessment subcommittee of the american academy of neurology. Neurology70(19),1707–1714 (2008).
    • 36  Lindblad CI, Hanlon JT, Gross CR et al.: Clinically important drug–disease interactions and their prevalence in older adults. Clin. Ther.28(8),1133–1143 (2006).• Nice overview of drug–disease interactions with reference to the Beers criteria.
    • 37  Fick DM, Cooper JW, Wade WE et al.: Updating the Beers criteria for potentially inappropriate medication use in older adults: results of a US consensus panel of experts. Arch. Intern. Med.163(22),2716–2724 (2003).
    • 38  Aspinall S, Sevick MA, Donohue J et al.: Medication errors in older adults: a review of recent publications. Am. J. Geriatr. Pharmacother. (1),75–84 (2007).
    • 39  Askmark H, Lundberg PO, Olsson S: Drug-related headache. Headache (7),441–444 (1989).
    • 40  Kunkel RS: Headaches in older patients: Special problems and concerns. Cleve. Clin. J. Med.73(10),922–928 (2006).
    • 41  Lie JT: Illustrated histopathologic classification criteria for selected vasculitis syndromes. American College of Rheumatology Subcommittee on classification of vasculitis. Arthritis Rheum.33(8),1074–1087 (1990).
    • 42  Smetana GW, Shmerling RH: Does this patient have temporal arteritis? JAMA287(1),92–101 (2002).•• Systematic review and discussion of the most common secondary headache in the elderly.
    • 43  Pfadenhauer K, Weber H: Duplex sonography of the temporal and occipital artery in the diagnosis of temporal arteritis. A prospective study. J. Rheumatol. (10),2177–2181 (2003).
    • 44  Diaz VA, DeBroff BM, Sinard J: Comparison of histopathologic features, clinical symptoms, and erythrocyte sedimentation rates in biopsy-positive temporal arteritis. Ophthalmology112(7),1293–1298 (2005).
    • 45  Salvarani C, Cantini F, Hunder GG: Polymyalgia rheumatica and giant-cell arteritis. Lancet372(9634),234–245 (2008).
    • 46  Kawasaki A, Purvin V: Giant cell arteritis: an updated review. Acta Ophthalmol. DOI: 10.1111/j.1755-3768.2008.01314.x (2008) (Epub ahead of print).
    • 47  Hoffman GS, Cid MC, Hellmann DB et al.: A multicenter, randomized, double-blind, placebo-controlled trial of adjuvant methotrexate treatment for giant cell arteritis. Arthritis Rheum.46(5),1309–1318 (2002).
    • 48  Mahr AD, Jover JA, Spiera RF et al.: Adjunctive methotrexate for treatment of giant cell arteritis: an individual patient data meta-analysis. Arthritis Rheum.56(8),2789–2797 (2007).
    • 49  Lipton RB, Bigal ME, Steiner TJ et al.: Classification of primary headaches. Neurology63(3),427–435 (2004).
    • 50  Evers S, Goadsby PJ: Hypnic headache: Clinical features, pathophysiology, and treatment. Neurology60(6),905–909 (2003).
    • 51  Ulrich K, Gunreben B, Lang E et al.: Pregabalin in the therapy of hypnic headache. Cephalalgia26(8),1031–1032 (2006).
    • 52  Buzzi MG, Cologno D, Formisano R et al.: Hypnic headache responsive to indomethacin: second italian case. Funct. Neurol.20(2),85–87 (2005).
    • 53  Moon HS, Chung CS, Hong SB et al.: A case of symptomatic hypnic headache syndrome. Cephalalgia26(1),81–83 (2006).
    • 54  Kerr E, Hewitt R, Gleadhill I: Benign headache in the elderly – a case report of hypnic headache. Ulster Med. J.75(2),158–159 (2006).
    • 55  Liang JF, Fuh JL, Yu HY et al.: Clinical features, polysomnography and outcome in patients with hypnic headache. Cephalalgia28(3),209–215 (2008).
    • 56  Evers S: Comparison of cervicogenic headache with migraine. Cephalalgia28(Suppl. 1),16–17 (2008).
    • 57  Sjaastad O: Cervicogenic headache: comparison with migraine without aura; Vaga study. Cephalalgia28(Suppl. 1),18–20 (2008).
    • 58  Sjaastad O, Fredriksen TA, Pfaffenrath V: Cervicogenic headache: diagnostic criteria. Headache30(11),725–726 (1990).
    • 59  Jansen J: Surgical treatment of cervicogenic headache. Cephalalgia28(Suppl. 1),41–44 (2008).
    • 60  Naja ZM, El-Rajab M, Al-Tannir MA et al.: Repetitive occipital nerve blockade for cervicogenic headache: expanded case report of 47 adults. Pain Pract.6(4),278–284 (2006).
    • 61  Sycha T, Kranz G, Auff E et al.: Botulinum toxin in the treatment of rare head and neck pain syndromes: a systematic review of the literature. J. Neurol.251(Suppl. 1),I19–I30 (2004).
    • 62  Gronseth G, Cruccu G, Alksne J et al.: Practice parameter: the diagnostic evaluation and treatment of trigeminal neuralgia (an evidence-based review): report of the quality standards subcommittee of the American Academy of Neurology and the European Federation of Neurological Societies. Neurology71(15),1183–1190 (2008).•• Outstanding current evidence-based overview of diagnosis and treatment of trigeminal neuralgia.
    • 63  He L, Wu B, Zhou M: Non-antiepileptic drugs for trigeminal neuralgia. Cochrane Database Syst. Rev.3,CD004029 (2006).
    • 64  Wiffen P, Collins S, McQuay H, Carroll D et al.: Anticonvulsant drugs for acute and chronic pain. Cochrane Database Syst. Rev. (3),CD001133 (2005).
    • 65  Wiffen PJ, Rees J: Lamotrigine for acute and chronic pain. Cochrane Database Syst. Rev. (2),CD006044 (2007).
    • 66  Cetas JS, Saedi T, Burchiel KJ: Destructive procedures for the treatment of nonmalignant pain: a structured literature review. J. Neurosurg.109(3),389–404 (2008).
    • 67  Constantoyannis C, Kagadis G, Chroni E: Percutaneous balloon compression for trigeminal neuralgias and autonomic Cephalalgia. Headache48(1),130–134 (2008).
    • 68  Williams MH, Broadley SA: SUNCT and SUNA: clinical features and medical treatment. J. Clin. Neurosci.15(5),526–534 (2008).
    • 69  Cohen AS, Matharu MS, Goadsby PJ: SUNCT syndrome in the elderly. Cephalalgia24(6),508–509 (2004).
    • 70  Cohen AS, Matharu MS, Goadsby PJ: Short-lasting unilateral neuralgiform headache attacks with conjunctival injection and tearing (SUNCT) or cranial autonomic features (SUNA) – a prospective clinical study of SUNCT and SUNA. Brain129(Pt 10),2746–2760 (2006).
    • 71  Cittadini E, Matharu MS, Goadsby PJ: Paroxysmal hemicrania: a prospective clinical study of 31 cases. Brain131(Pt 4),1142–1155 (2008).